news_6

Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company

Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class agents and proprietary platforms Initial...

news_6

Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company

Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class agents and proprietary platforms Initial...

news_6

Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company

Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class agents and proprietary platforms Initial...